A pharmaceutical products manufacturer, Intravenous infusions limited, is urging the swift release of the stimulus package to assist in its operations.
The company is yet to receive the support after a year of applying for the funding.
The company’s Managing Director, David Klutse is also hopeful of its expansion into other West African countries with the support.
The comments come at a time where some businesses have also complained of the delay in releasing the stimulus package to support their operations.
Intravenous infusion limited is to benefit from at least 5 million dollars from the stimulus package.
Its Managing Director, David Klutse explains that the delay has rather slowed the planned expansion to be carried out this year.
He wants the Ministry of Trade and Industry to expedite action to provide the support as soon as possible.
“We also want to seek additional funding which will help us equip the company with the equipment that we need. With this we can then increase our production capacity,” he stated.
The Trade Ministry recently announced that it has advanced about 141 million cedis to some six companies.
Again, some twenty businesses were tipped to be provided with funding support by the Ministry.
The AGI for instance is yet to confirm the actual disbursements to its members though it is aware of some shortlisted members.
Meanwhile intravenous infusion is seeking that the government pays all outstanding debts to their respective district hospitals and regional medical stores.
This Mr. Klutse maintains will in turn lead to the payment of the outstanding 10 million cedis debt.
“Government when they took office made efforts to clear majority of the debts especially in June of 2017…We were actually able to collect a lot of the debts but we are hoping to get the remainder paid, ” he added.